Table 1. Demographic characteristics and clinical features of overweight patients with hyperuricemia at baseline.
| BMI <25 kg/m2 (n=1296) | BMI ≥25 kg/m2 (n=3382) | P-value | |
|---|---|---|---|
| Age (years), Number (%) | |||
| >60 | 693(45.8) | 315(9.3) | <0.05 |
| 35-60 | 306(23.6) | 2501(74.0) | <0.05 |
| 18-35 | 297(22.9) | 566(16.7) | >0.05 |
| Sex (Male), Number (%) | 459(35.4) | 2685(79.4) | <0.05 |
| Sex (Female), Number (%) | 837(64.6) | 697(20.6) | <0.05 |
| Waist circumference, cm, abnormal, Number (%) | 45(3.5) | 2622(77.5) | <0.05 |
| Elevated blood pressure, Number (%) | 576(44.4) | 2188(64.7) | <0.05 |
| SBP, mm Hg | 137.1±26.4 | 143.4±29.5 | >0.05 |
| DBP, mmHg | 68.7±11.5 | 72.4±13.8 | >0.05 |
| Low HDL, n | 491(37.9) | 2653(78.4) | <0.05 |
| Elevated TG, n | 213(16.4) | 2759(81.6) | <0.05 |
| Elevated fasting glucose, n | 317(24.5) | 2036(60.2) | <0.05 |
| Serum UA level, mg/dl | 8.05 ± 1.24 | 8.38 ± 1.37 | >0.05 |
Abnormal waist circumference: ≥90 cm (male) or ≥80 cm (female); Elevated blood pressure : ≥130/85 mm Hg or on hypertension prescription; low HDL : < 1.03 mmol/L (male) or <1.30 mmol/L (female); elevated TG : ≥2.28 mmol/L (within 4h since last meal) and ≥1.7 mmol/L (above 4h since last meal) or on lipid lowering drugs; elevated fasting glucose: ≥ 7.8 mmol/L (within 4 h since last meal) and ≥5.6 mmol/L (above 4 h since last meal) or on glucose lowering prescription; BMI: body mass index, UA: uric acid, TG: triglycerides, HDL: high-density lipoprotein, SBP: systolic blood pressure, DBP: diastolic blood pressure.